← Back to all trials
Not Yet Recruiting
NCT07835555
Smoking Cessation Medication And Rewards Using a Teamlet to Treat Tobacco Use Disorder (SMARTTT 2.0) Among Persons With HIV: A Multi-site Hybrid Type 2 Effectiveness-implementation Trial
Conditions: Tobacco Use Disorder/Cigarette Smoking, HIV
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: PHASE4
Enrollment: 794
Sponsor: Yale University
Location: Bridgeport Hospital Primary Care Center Infectious Disease Clinic Bridgeport Connecticut
Summary
Cigarette smoking is an important cause of illness and death among persons with HIV (PWH). This project will study the impact of adding contingency management (use of financial rewards) to receiving medications and counseling on promoting smoking abstinence and other health outcomes among PWH. As treatments will be provided by clinical pharmacists and other team members in HIV clinics, factors relevant for implementing this model to inform real-world practice will also be evaluated.
Eligibility Criteria
Inclusion Criteria:
* Have been diagnosed with HIV;
* Receive care at one of the participating sites;
* Are \>18 years old;
* Have smoked \>100 cigarettes lifetime;
* Smoke everyday or some days;
* Smoke, on average, \>5 cigarettes per day; and
* Provide written informed consent.
Exclusion Criteria:
* Exclusive use of non-cigarette tobacco or nicotine products, including e-cigarettes;
* Self-report or urine testing confirming pregnancy, nursing, or trying to conceive;
* Life-threatening or unstable medical, surgical, or psychiatric condition;
* Anticipate being unable to return for follow-up for any reason, such as travel, planned procedure;
* Inability to provide \>1 form of contact information;
* Inability to read or understand English or Spanish.
Source: ClinicalTrials.gov (NCT07835555). StuddyBuddy aggregates publicly available trial information.
